Medicines 
Dealstreet

Samisti Legal, Trilegal act on Piramal Pharma acquiring minority stake in Yapan Bio for ₹101.77 crore

The acquisition took place through primary and secondary purchase of shares.

Bar & Bench

Piramal Pharma acquires minority stake in Yapan Bio for ₹101.77 crore.

Samisti Legal acted as the legal counsel to Yapan Bio. The team was led by Prashant Jain (Partner) and assisted by Anita Dugar (Principal Associate).

Trilegal acted for Piramal Pharma.

The investment will allow Piramal Pharma to strengthen Piramal Pharma Solutions (PPS), its Contract Development and Manufacturing Organization (CDMO) business, by broadening its service offerings.

The acquisition took place through primary and secondary purchase of shares.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Delhi High Court upholds BPL's ₹1,378 crore liability despite 'exorbitant' interest rate

Supreme Court protects 6 Congress MLAs from disqualification after Himachal HC ruling

Plea in Kerala High Court to ensure local authorities appoint custodian of living wills

Kerala High Court slams political parties over flash hartal in landslide-hit Wayanad

Karnataka High Court dismisses Prajwal Revanna anticipatory bail plea in fourth sexual assault case

SCROLL FOR NEXT